Stephane L. Raeppel

3194, Rue Claude Jodoin
Montreal, QC H1Y3M2, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

An alignment-independent three-dimensional quantitative structure-activity relationship study on ron receptor tyrosine kinase inhibitors.

An alignment-independent three-dimensional quantitative structure-activity relationship study on ron receptor tyrosine kinase inhibitors.

Journal: Journal of bioinformatics and computational biology

Published: July 26, 2022

A potential signaling axis between RON kinase receptor and hypoxia-inducible factor-1 alpha in pancreatic cancer.

A potential signaling axis between RON kinase receptor and hypoxia-inducible factor-1 alpha in pancreatic cancer.

Journal: Molecular carcinogenesis

Published: May 21, 2021

Ligand-based Discovery of Novel Small Molecule Inhibitors of RON Receptor Tyrosine Kinase.

Ligand-based Discovery of Novel Small Molecule Inhibitors of RON Receptor Tyrosine Kinase.

Journal: Molecular informatics

Published: July 23, 2020

When RON MET TAM in Mesothelioma: All Druggable for One, and One Drug for All?

When RON MET TAM in Mesothelioma: All Druggable for One, and One Drug for All?

Journal: Frontiers in endocrinology

Published: October 30, 2018

Design, synthesis and RON receptor tyrosine kinase inhibitory activity of new head groups analogs of LCRF-0004.

Design, synthesis and RON receptor tyrosine kinase inhibitory activity of new head groups analogs of LCRF-0004.

Journal: Bioorganic & medicinal chemistry letters

Published: June 19, 2015

Design and synthesis of constrained analogs of LCRF-0004 as potent RON tyrosine kinase inhibitors.

Design and synthesis of constrained analogs of LCRF-0004 as potent RON tyrosine kinase inhibitors.

Journal: Bioorganic & medicinal chemistry letters

Published: May 08, 2015

Design and synthesis of close analogs of LCRF-0004, a potent and selective RON receptor tyrosine kinase inhibitor.

Design and synthesis of close analogs of LCRF-0004, a potent and selective RON receptor tyrosine kinase inhibitor.

Journal: Bioorganic & medicinal chemistry letters

Published: March 06, 2015

Identification of a Novel Series of Potent TrkA Receptor Tyrosine Kinase Inhibitors.

Identification of a Novel Series of Potent TrkA Receptor Tyrosine Kinase Inhibitors.

Journal: International journal of medicinal chemistry

Published: December 05, 2011

Showing 1-8 of 8

Last Updated: 09/26/2026